Literature DB >> 19109153

IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.

Shana M Coley1, Mandy L Ford, Samantha C Hanna, Maylene E Wagener, Allan D Kirk, Christian P Larsen.   

Abstract

CD8 T cells are necessary for costimulation blockade-resistant rejection. However, the mechanism by which CD8 T cells mediate rejection in the absence of major costimulatory signals is poorly understood. IFN-gamma promotes CD8 T cell-mediated immune responses, but IFN-gamma-deficient mice show early graft loss despite costimulation blockade. In contrast, we found that IFN-gamma receptor knockout mice show dramatically prolonged graft survival under costimulation blockade. To investigate this paradox, we addressed the effects of IFN-gamma on T cell alloresponses in vivo independent of the effects of IFN-gamma on graft survival. We identified a donor-specific CD8 T cell breakthrough response temporally correlated with costimulation blockade-resistant rejection. Neither IFN-gamma receptor knockout recipients nor IFN-gamma-deficient recipients showed a CD8 breakthrough response. Graft death on IFN-gamma-deficient recipients despite costimulation blockade could be explained by the lack of IFN-gamma available to act on the graft. Indeed, the presence of IFN-gamma was necessary for graft survival on IFN-gamma receptor knockout recipients, as either IFN-gamma neutralization or the lack of the IFN-gamma receptor on the graft precipitated early graft loss. Thus, IFN-gamma is required both for the recipient to mount a donor-specific CD8 T cell response under costimulation blockade as well as for the graft to survive after allotransplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19109153      PMCID: PMC2683416          DOI: 10.4049/jimmunol.182.1.225

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Fuel feeds function: energy metabolism and the T-cell response.

Authors:  Casey J Fox; Peter S Hammerman; Craig B Thompson
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

3.  The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.

Authors:  Wensheng Lin; Samantha L Bailey; Hanson Ho; Heather P Harding; David Ron; Stephen D Miller; Brian Popko
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

4.  CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.

Authors:  Carole Guillonneau; Marcelo Hill; François-Xavier Hubert; Elise Chiffoleau; Caroline Hervé; Xian-Liang Li; Michèle Heslan; Claire Usal; Laurent Tesson; Séverine Ménoret; Abdelhadi Saoudi; Brigitte Le Mauff; Régis Josien; Maria Cristina Cuturi; Ignacio Anegon
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

5.  An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.

Authors:  A S Diamond; R G Gill
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

6.  Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm.

Authors:  K S Famulski; B Sis; L Billesberger; P F Halloran
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

Review 7.  Cell type-specific signaling in response to interferon-gamma.

Authors:  A H H van Boxel-Dezaire; G R Stark
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

8.  Direct interferon-gamma signaling dramatically enhances CD4+ and CD8+ T cell memory.

Authors:  Jason K Whitmire; Boreth Eam; Nicola Benning; J Lindsay Whitton
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  Role of IFNgamma in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells.

Authors:  P Thebault; T Condamine; M Heslan; M Hill; I Bernard; A Saoudi; R Josien; I Anegon; M C Cuturi; E Chiffoleau
Journal:  Am J Transplant       Date:  2007-09-14       Impact factor: 8.086

Review 10.  Costimulation blockade in autoimmunity and transplantation.

Authors:  Flavio Vincenti
Journal:  J Allergy Clin Immunol       Date:  2008-02       Impact factor: 10.793

View more
  12 in total

1.  CD28 blockade induces division-dependent downregulation of interleukin-2 receptor alpha.

Authors:  Mandy L Ford; Linda L Stempora; Christian P Larsen
Journal:  Transpl Immunol       Date:  2010-11-10       Impact factor: 1.708

2.  Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.

Authors:  Roxane Lemoine; Florence Velge-Roussel; Florence Herr; Romain Felix; Hubert Nivet; Yvon Lebranchu; Christophe Baron
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

3.  MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection.

Authors:  Amelia R Hofstetter; Mandy L Ford; Lucy C Sullivan; Jarad J Wilson; Annette Hadley; Andrew G Brooks; Aron E Lukacher
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

Review 4.  Translating costimulation blockade to the clinic: lessons learned from three pathways.

Authors:  Mandy L Ford; Christian P Larsen
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

5.  Effector T Cells and Ischemia-Induced Systemic Angiogenesis in the Lung.

Authors:  Qiong Zhong; John Jenkins; Aigul Moldobaeva; Franco D'Alessio; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

6.  IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells.

Authors:  Beatrice Bolinger; Daniel Engeler; Philippe Krebs; Simone Miller; Sonja Firner; Matthias Hoffmann; Douglas C Palmer; Nicholas P Restifo; Yinghua Tian; Pierre-Alain Clavien; Burkhard Ludewig
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

7.  CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.

Authors:  Elizabeth A Lendermon; Jeffrey M Dodd-o; Tiffany A Coon; Hannah L Miller; Sudipto Ganguly; Iulia Popescu; Christopher P O'Donnell; Nayra Cardenes; Melanie Levine; Mauricio Rojas; Nathaniel M Weathington; Jing Zhao; Yutong Zhao; John F McDyer
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

8.  A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response.

Authors:  Aron Chakera; Sophia C Bennett; Richard J Cornall
Journal:  J Transl Med       Date:  2011-08-26       Impact factor: 5.531

9.  Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.

Authors:  Jonathan M Beus; Salila S Hashmi; Saranya A Selvaraj; Danxia Duan; Linda L Stempora; Stephanie A Monday; Jennifer A Cheeseman; Kelly M Hamby; Samuel H Speck; Christian P Larsen; Allan D Kirk; Leslie S Kean
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

Authors:  Bruce M Hall; Giang T Tran; Nirupama D Verma; Karren M Plain; Catherine M Robinson; Masaru Nomura; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2013-08-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.